IdentifySensors 생물학적 제제제공
IdentifySensors Biologics에 투자하십시오.
IdentifySensors Biologics에 투자하십시오.
Jim Segermark CEO of InSitu 생물 제제 InSitu 생물 제제 is an emerging ... Sign Up For the Event Free InSitu 생물 제제 & 맨해튼 스트리트 ... 생물 제제 – Matrix BioHydrogel™ & AnestaGel™ Jim Segermark, CEO InSitu ...
Anestagel에 투자하십시오. 새로운, opioid-free 진통제.
subjects." InSitu 생물 제제' AnestaGel™, non-opioid pain relief drug based ... Qualification of InSitu 생물학적’s RegA+ Offering, numerous previous investors ...
RodTurner's blog When InSitu 생물 제제, Inc. opened its Reg A+ pre-revenue equity offering to IRA investors in 2018, company President and CEO ... it for the higher-risk part of their portfolio,” he explained. InSitu 생물 제제 ...
7:00PM Networking EXPERTS: Jim Segermark | Host; CEO, InSitu 생물 제제 ... About InSitu 생물 제제 InSitu 생물 제제 is an emerging biotech company, ... Segermark, CEO of InSitu 생물 제제 1-651-338-4801 | [이메일 보호] ...
is in the early stages of an annual $90 billion market opportunity. InSitu 생물 제제 ... OUT INSITU 생물학 여기. 여기에서 제안 안내장을 확인하세요...
their Offering Circular HERE. InSitu 생물 제제 InSitu 생물 제제 is an emerging ...
View our Offering Circular HERE. InSitu 생물 제제- AnestaGel™ InSitu 생물 제제 is an emerging biotech company focusing on the development of ...
a Regulation A+ for a company insights to 생물 제제 and non-opioid pain killing, ... in that. Okay. Hi, 미니마 마스크, 형. 따라서 회사는 때때로 ...